Recent 13F filings as of December 2025 show that 173 institutional investors hold a position in Nektar Therapeutics (NASDAQ:NKTR).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BVF INC/IL | 31 Dec, 2025 | 1,559,595 | 283,000 | 22.17% | $65,939,677.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,027,089 | 78,442 | 8.27% | $43,425,322.00 |
| Two Seas Capital LP | 31 Dec, 2025 | 745,185 | 745,185 | 0.00% | $31,506,422.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 645,607 | 36,493 | 5.99% | $27,296,262.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 596,000 | 328,000 | 122.39% | $25,198,880.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 566,421 | -362,730 | -39.04% | $23,948,280.00 |
| Prosight Management, LP | 31 Dec, 2025 | 554,633 | 554,633 | 0.00% | $23,449,883.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 473,014 | 38,777 | 8.93% | $19,999,032.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 454,075 | -116,919 | -20.48% | $19,198,291.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 438,630 | 320,211 | 270.41% | $18,545,276.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 433,419 | 309,761 | 250.50% | $18,324,955.00 |
| EMERALD ADVISERS, LLC | 31 Dec, 2025 | 384,342 | 61,096 | 18.90% | $16,249,980.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 383,310 | -541,586 | -58.56% | $16,206,346.00 |
| 22NW, LP | 31 Dec, 2025 | 331,115 | 0 | 0.00% | $13,999,542.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 323,915 | 319,941 | 8,050.86% | $13,695,126.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 309,777 | -51,296 | -14.21% | $13,097,371.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 308,414 | 129,506 | 72.39% | $13,039,744.00 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 31 Dec, 2025 | 295,716 | 123,940 | 72.15% | $12,502,872.00 |
| UBS Group AG | 31 Dec, 2025 | 287,561 | 196,739 | 216.62% | $12,158,079.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 282,021 | 99,207 | 54.27% | $11,923,848.00 |